Elsie M Eugui

This inventor holds 18 USPTO granted patents, primarily in Autoimmune Treatments. Top assignees: Syntex (u.s.a.) Inc., Roche Palo Alto LLC. Active years: 1987-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elsie M Eugui. Retrieved from https://idiyas.com/inventor/elsie-m-eugui

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 18

% Patents Active = 83.3

Average Co-Inventor Count = 5.1

ph-index = 16

Forward Citations = 473(Granted Patents)

Company Filing History:

Years Active: 1987-2015

Loading Chart...

Areas of Expertise:

Anti-OX40L Antibodies

Mycophenolic Acid

Rheumatoid Arthritis

Inflammatory Diseases

Allograft Rejection

Monoclonal Antibodies

Morpholinoethyl Esters

Heterocyclic Aminoalkyl Esters

Psoriatic Diseases

Autoimmune Diseases

Pharmaceutical Derivatives

Treatment Methods

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9102733 - Anti-OX40L antibodies (2015-08-11),

2. 7868141 - Anti-OX40L antibodies (2011-01-11),

3. 7501496 - Anti-OX40L antibodies (2009-03-10),

4. 5177072 - Treatment of autoimmune inflammatory, and psoriatic diseases with (1993-01-05),

5. 4992467 - Treatment of autoimmune diseases with mycophenolic acid, and derivatives (1991-02-12),

6. 4959387 - Mycophenolic acid derivatives in the treatment of rheumatoid arthritis (1990-09-25),

7. 4952579 - Method of treating diseases by administering morpholino-ethylester of (1990-08-28),

8. 4948793 - Treatment of autoimmune diseases with the morpholinoethyl ester of (1990-08-14),

9. 4935343 - Monoclonal antibodies for interleukin-1.beta. (1990-06-19),

10. 4868153 - Treatment of allograft rejection with mycophenolic acid, its (1989-09-19),

11. 4861776 - Heterocyclic aminoalkyl esters of mycophenolic acid and derivatives (1989-08-29),

12. 4808592 - Method of treating diseases by administering morpholinoethylester of (1989-02-28),

13. 4786637 - Treatment of allograft rejection with mycophenolic acid (1988-11-22),

14. 4753935 - Morpholinoethylesters of mycophenolic acid and pharmaceutical (1988-06-28),

15. 4748173 - Heterocyclic aminoalkyl esters of mycophenolic acid and derivatives (1988-05-31),

Certainly! Here is the article about inventor Elsie M Eugui:

Title: The Innovative Work of Elsie M Eugui: A Pioneer in Medical Breakthroughs

Introduction:

Elsie M Eugui, a prominent inventor hailing from Belmont, CA (US), has made significant contributions to the field of biomedical research. With an impressive portfolio of 18 patents, her groundbreaking work has revolutionized the treatment of inflammatory diseases.

Latest Patents:

Among her latest patents is the creation of Anti-OX40L antibodies. These antibodies, along with their variants containing a Fc part derived from human origin and devoid of binding to complement factor C1q, have demonstrated novel properties that offer immense therapeutic benefits to patients battling inflammatory conditions.

Career Highlights:

Elsie M Eugui has left an indelible mark on the industry through her tenure at renowned companies such as Syntex (USA) Inc. and Roche Palo Alto LLC. Her expertise and dedication have driven groundbreaking advancements in the development of cutting-edge medical treatments.

Collaborations:

Throughout her illustrious career, Elsie M Eugui has collaborated with esteemed professionals such as Anthony C Allison and Peter H Nelson. This collaborative spirit has fostered a dynamic environment of innovation, leading to the successful realization of pioneering medical solutions.

Conclusion:

In conclusion, Elsie M Eugui's relentless pursuit of innovation and her unwavering commitment to improving patient outcomes underscore her status as a trailblazer in the realm of biomedical inventions. Her groundbreaking work serves as a testament to the transformative power of innovative thinking in advancing medical science and enhancing the quality of healthcare globally.

I hope this article provides you with valuable insights into the remarkable achievements of inventor Elsie M Eugui.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]